Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave-Reference-Cited by-同舟云学术

Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave

Published:2023-03 Issue: Volume:128 Page:347-354
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Yamamoto Shohei^ORCID,Matsuda Kouki,Maeda Kenji,Horii Kumi,Okudera Kaori,Oshiro Yusuke,Inamura Natsumi,Takeuchi Junko S.,Konishi Maki,Ozeki Mitsuru,Mizoue Tetsuya,Sugiyama Haruhito^ORCID,Aoyanagi Nobuyoshi^ORCID,Mitsuya Hiroaki,Sugiura Wataru,Ohmagari Norio

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference21 articles.

1. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar;Chemaitelly;N Engl J Med,2021

2. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months;Levin;N Engl J Med,2021

3. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant;Andrews;N Engl J Med,2022

4. Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants;Tseng;Nat Med,2022

5. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4–5 vaccine and practical application of dried blood spots;Vaccine;2024-09

2. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination;Infectious Diseases Now;2024-08

3. Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4-5 vaccine and practical application of dried blood spots;2024-01-30

4. Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population;Vaccines;2024-01-20

5. Association between levels of receptor binding domain antibodies of SARS-CoV-2, receipt of booster and risk of breakthrough infections: LA pandemic surveillance cohort study;Scientific Reports;2023-11-25